Picture of Mesoblast logo

MSB Mesoblast Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

Annual cashflow statement for Mesoblast, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
C2020
June 30th
C2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital33.127.36.21109.39
Other Operating Cash Flow
Cash from Operating Activities-57.8-50.4-101-65.8-63.3
Capital Expenditures-0.279-2.1-1.65-0.157-0.264
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.721-1.180-0.0750.07
Sale/Maturity of Investment
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-1-3.27-1.65-0.232-0.194
Financing Cash Flow Items-2.22-12.2-7.77-11.8-11.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities71.6131109-9.8774.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash12.778.97.55-76.410.9